Results 261 to 270 of about 91,730 (350)

Beyond PD‐1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next‐Generation Immune Strategies

European Journal of Haematology, EarlyView.
ABSTRACT PD‐1 inhibitors have reshaped the treatment landscape of classical Hodgkin lymphoma, yet a substantial proportion of patients exhibit primary or acquired resistance driven by tumor‐intrinsic alterations, immunosuppressive microenvironmental signals, metabolic constraints, and EBV‐mediated modulation.
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, Maria Eugenia Alvaro, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Ernesto Vigna, Fortunato Morabito, Massimo Gentile   +12 more
wiley   +1 more source

Predictors of parental acceptance to live attenuated influenza vaccine for children [PDF]

Shujuan Qu, Min Zhou, Kathryn S. Campy, Wei He   +3 more
openalex   +1 more source

Reining in strangles: Absence of disease in horses vaccinated with a DIVA‐compatible recombinant fusion protein vaccine, Strangvac, following natural exposure to Streptococcus equi subspecies equi

Equine Veterinary Journal, EarlyView.
Abstract Background Strangles, caused by Streptococcus equi subspecies equi (S. equi), is a prevalent infectious disease of horses. This is the first report on the use of a new vaccine, Strangvac, in a natural outbreak of strangles. Objectives To measure the effects of Strangvac vaccination during an outbreak of strangles at a Swedish farm.
Gittan Gröndahl, Francesco Righetti, Anna Aspán, Joakim Bjerketorp, Sara Frosth, Lars Frykberg, Karin Jacobsson, Bengt Guss, Romain Paillot, Jan‐Ingmar Flock, Birgitta Henriques‐Normark, Andrew S. Waller   +11 more
wiley   +1 more source

Perspectives on Pertussis Prevention

Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Protein nanoparticles assemble in plants, display antigenic viral peptides, and produce an epitope‐specific immune response

The FEBS Journal, EarlyView.
Current methods to control porcine reproductive and respiratory syndrome, a disease affecting pigs, are insufficient and a safer, more effective vaccine is needed. This study describes the design and plant production of a self‐assembling protein nanoparticle vaccine candidate against this disease.
Jordan T. VanderBurgt, Richard Strasser, Hong Zhu, Angelo Kaldis, Christopher P. Garnham, Rima Menassa   +5 more
wiley   +1 more source

Epitope-Containing Short Peptides Capture Distinct IgG Serodynamics That Enable Differentiating Infected from Vaccinated Animals for Live-Attenuated Vaccines. [PDF]

J Virol, 2020
Xue Q, Xu H, Liu H, Pan J, Yang J, Sun M, Chen Y, Xu W, Cai X, Ma H.   +9 more
europepmc   +1 more source

‘I Don't Want Another Five Years of “The Only Thing We Talk About Is Brexit”’: The Dynamics of EU (De)politicisation in Post‐Brexit Britain

JCMS: Journal of Common Market Studies, EarlyView.
Abstract The 2016 Brexit referendum was a watershed moment for the politicisation of the European Union (EU) in the United Kingdom. Much has been written about the politicising effects of the referendum, along with the Leave result's subsequent contestation in the media as well as in national and European election cycles.
Anne‐Marie Houde, Louis Stockwell
wiley   +1 more source

The association between COVID‐19 and incident gestational diabetes (GDM): A population‐based case–control study of the National Health Insurance Research Database in Taiwan

Journal of Diabetes Investigation, EarlyView.
Our study found no evidence that COVID‐19 infection is linked to gestational diabetes; however, it shows some evidence of an association between vaccination and a reduced risk. ABSTRACT Background Reports suggested that diabetes could be a complication arising from COVID‐19; however, the relationship between COVID‐19 and the development of gestational ...
Liang‐Yu Lin, Chi‐Jen Chen, Mei‐Huei Chen, Chun‐Wei Chen, Pau‐Chung Chen   +4 more
wiley   +1 more source

Live Attenuated Influenza Vaccine [PDF]

, 2020
openaire   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source